In the current work, we used global Npr1 gene‐targeted male and female mice to determine the effect of class I selective HDAC inhibitor (HDACi), mocetinostat (MGCD0103; MGCD), to identify the role of class I HDACs in sex‐specific differential regulation of hypertension and renal dysfunction and injury. This evidence concerns the gene HDAC9 and hypertensive disorder.